Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma

Por Vishwamitra, Deeksha, Shi, Ping, Wilson, Desiree, Manshouri, Roxsan, Vega, Francisco, Schlette, Ellen J., Amin, Hesham M.
Publicado em 2011

p53 Expression by Immunohistochemistry is an Independent Determinant of Survival in Chronic Lymphocytic Leukemia Patients Receiving Frontline Chemo-Immunotherapy

Por Schlette, Ellen J, Admirand, Joan, Wierda, William, Abruzzo, Lynne, O'Brien, Susan, Lerner, Susan, Keating, Michael J, Tam, Constantine
Publicado no Leuk Lymphoma (2009)

Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression

Por Admirand, Joan H., Knoblock, Ronald J., Coombes, Kevin R., Tam, Constantine, Schlette, Ellen J., Keating, Michael J., Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Abruzzo, Lynne V.
Publicado em 2010

Expression of serine 194–phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non–Hodgkin lymphomas

Por Drakos, Elias, Leventaki, Vasiliki, Atsaves, Vasileios, Schlette, Ellen J., Lin, Pei, Vega, Francisco, Miranda, Roberto N., Claret, Francois-Xavier, Medeiros, L. Jeffrey, Rassidakis, George Z.
Publicado em 2011

mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells

Por Chen, Weina, Drakos, Elias, Grammatikakis, Ioannis, Schlette, Ellen J, Li, Jiang, Leventaki, Vasiliki, Staikou-Drakopoulou, Efi, Patsouris, Efstratios, Panayiotidis, Panayiotis, Medeiros, L Jeffrey, Rassidakis, George Z
Publicado em 2010

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

Por Ferrajoli, Alessandra, Lee, Bang-Ning, Schlette, Ellen J., O'Brien, Susan M., Gao, Hui, Wen, Sijin, Wierda, William G., Estrov, Zeev, Faderl, Stefan, Cohen, Evan N., Li, Changping, Reuben, James M., Keating, Michael J.
Publicado em 2008

Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia

Por Falchi, Lorenzo, Keating, Michael J., Marom, Edith M., Truong, Mylene T., Schlette, Ellen J., Sargent, Rachel L., Trinh, Long, Wang, Xuemei, Smith, Susan C., Jain, Nitin, Estrov, Zeev, O’Brien, Susan, Wierda, William G., Lerner, Susan, Ferrajoli, Alessandra
Publicado em 2014

Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors

Por Strati, Paolo, Schlette, Ellen J., Solis Soto, Luisa M., Duenas, Daniela E., Sivina, Mariela, Kim, Ekaterina, Keating, Michael J., Wierda, William G., Ferrajoli, Alessandra, Kantarjian, Hagop, Estrov, Zeev, Jain, Nitin, Thompson, Philip A., Wistuba, Ignacio I., Burger, Jan A.
Publicado no Blood (2020)

Whole-Genome Scanning by Array Comparative Genomic Hybridization as a Clinical Tool for Risk Assessment in Chronic Lymphocytic Leukemia

Por Gunn, Shelly R., Mohammed, Mansoor S., Gorre, Mercedes E., Cotter, Philip D., Kim, Jaeweon, Bahler, David W., Preobrazhensky, Sergey N., Higgins, Russell A., Bolla, Aswani R., Ismail, Sahar H., de Jong, Daphne, Eldering, Eric, van Oers, Marinus H.J., Mellink, Clemens H.M., Keating, Michael J., Schlette, Ellen J., Abruzzo, Lynne V., Robetorye, Ryan S.
Publicado em 2008

A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma

Por Lyapichev, Kirill A., Piña-Oviedo, Sergio, Medeiros, L. Jeffrey, Evans, Mark G., Liu, Hui, Miranda, Alonso R., Hunt, Kelly K., Clemens, Mark W., Stewart, John M., Amin, Mitual B., Quesada, Andres E., Chai, Siaw Ming, Napoli, Arianna Di, Yoga, Arthy, Dave, Sanat K., Wistuba, Ignacio I., Wu, Yun, Bueso-Ramos, Carlos E., Schlette, Ellen J., Ferrufino-Schmidt, Maria C., Loghavi, Sanam, Khoury, Joseph D., Young, Ken H., Miranda, Roberto N.
Publicado no Mod Pathol (2019)